The obtained pDA-PEG NPs were successfully used as a fluorescent label for molecular imaging of cancer cells at N1000 nm by functionalizing with Cetuximab (Erbitux) for targeting EGFRs on the cell membranes of EGFR-positive breast tumor MDA-MB-468 cells. Here, EGFR is linked to cancer.